SLC2A5 and glioma: Due to the lack of the follow-up information of colorectal cancer and glioma patients, we analyzed the TCGA datasets via Human Protein Atlas website (https://www.proteinatlas.org/), and found that Glut5 was highly expressed in the colorectal cancer patients with poor outcome (Figure S2E), while the result was not statistically significant for glioma patients (Figure S2F).